年轻及中年患者Ross手术的长期结局
单中心回顾性分析2001至2023年252例Ross手术患者(平均年龄19.6岁),比较同种移植片与手工Dacron带瓣管道重建肺动脉的长期效果。早期死亡率1.6%,10年全因生存率94.3%,Ross相关再干预免除率89%;Dacron管道与同种移植片在右室流出道压差和再干预率上无显著差异。
要点
- 年轻患者Ross手术长期生存和瓣膜耐久性良好。
- Dacron带瓣管道可作为同种移植片的替代选择。
- 低龄是晚期主动脉瓣反流的独立预测因素。
核心结论
- Ross手术在年轻患者中表现出优异的长期生存和瓣膜耐久性。
- Dacron带瓣管道是肺动脉瓣置换中安全有效的同种移植片替代品。
研究设计与样本
- 单中心(印度班加罗尔Narayana Health)回顾性研究,纳入2001至2023年252例Ross手术患者。
- 平均年龄19.6岁(标准差12.5),肺动脉重建使用同种移植片176例或手工Dacron带瓣管道75例。
- 采用Kaplan-Meier估计和多变量回归模型分析长期结局。
主要发现
- 早期死亡率为1.6%,中位随访6.4年(四分位距0.8-15年)。
- 10年全因生存率94.3%(95% CI 91.0-97.7),Ross相关再干预免除率89%(95% CI 84-94)。
- Ross相关再干预16例(6%),其中外科再干预13例(自体移植片8例、肺动脉管道5例),球囊瓣膜成形术3例(管道狭窄)。
临床怎么用
- 对于年轻主动脉瓣病变患者,Ross手术可作为长期耐久性良好的选择。
- 在资源有限或同种移植片不可及时,可考虑使用手工Dacron带瓣管道重建肺动脉。
- 低龄患者术后需关注晚期主动脉瓣反流风险,加强随访。
局限性
- 单中心回顾性研究,可能存在选择偏倚。
- 中位随访时间6.4年,部分患者随访时间较短。
- 未报告Dacron管道与同种移植片组间的基线差异及混杂因素调整细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Ross procedure is a valuable option for aortic valve replacement in young patients, but concerns about autograft durability and limited homograft availability, especially in resource-limited settings, have limited its use. This study evaluated long-term outcomes of the Ross procedure, with a focus on the effectiveness of handmade Dacron (polyethylene terephthalate, Getinge/Maquet) valved conduits as an alternative to homografts. METHODS: The study retrospectively reviewed 252 patients (mean age, 19.6 [SD12.5] years) who underwent the Ross procedure between 2001 and 2023 at a single center (Narayana Health, Bengaluru, India). Pulmonary artery reconstruction was performed using pulmonary homografts (n = 176) or handmade Dacron valve conduits (n = 75). Long-term outcomes, including mortality, reintervention, and valve function, were analyzed using Kaplan-Meier estimates and multivariate regression models. RESULTS: Early mortality was 1.6%. Median follow-up was 6.4 years (interquartile range, 0.8-15 years). At 10 years, freedom from all-cause mortality was 94.3% (95% CI, 91.0-97.7), and freedom from Ross-related reintervention was 89% (95% CI, 84-94). Ross-related reinterventions were performed in 16 (6%) cases, 13 surgical (8 autograft, 5 pulmonary conduit) and 3 balloon valvuloplasties for conduit stenosis. Dacron valved conduits had similar mean right ventricular outflow tract gradients (17.5 [ 9.9] mm Hg vs 16.5 [12.7] mm Hg; P = .75) and comparable overall reintervention rates (2.6% vs 3.4%; P = .93). Younger age was the only independent predictor of late aortic regurgitation (adjusted odds ratio, 0.90; 95% CI, 0.82--0.98; P = .01). CONCLUSIONS: The Ross procedure demonstrates excellent long-term survival and valve durability in young patients. Dacron valve conduits offer a safe and effective alternative to homografts for pulmonary valve replacement.
引用
- Shetty V, Narayan P, Rao S, et al. The Ross Procedure in Young and Middle-Aged Patients: Long-Term Outcomes. Ann Thorac Surg. 2025. PMID: 40946887. doi:10.1016/j.athoracsur.2025.08.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。